North America Cardiovascular Surgery Devices Market Outlook to 2036 – Beating Heart Surgery Systems and Perfusion Disposables

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: April 27, 2026 Report Code: GDME21924CRDB-ST

Select Item

GlobalData’s “North America Cardiovascular Surgery Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Cardiovascular Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Beating Heart Surgery Systems and Perfusion Disposables

The North America Cardiovascular Surgery Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Cardiovascular Surgery Devices Market.
• Global corporate-level profiles of key companies operating within the North America Cardiovascular Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiovascular Surgery Devices is segmented as follows:

• Beating Heart Surgery Systems

• Perfusion Disposables

Reasons to Buy

The North America Cardiovascular Surgery Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Cardiovascular Surgery Devices Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Cardiovascular Surgery Devices Market, North America

2.1 Cardiovascular Surgery Devices Market, North America, Revenue ($m), 2024-2036

2.2 Cardiovascular Surgery Devices Market, North America, Revenue ($m), 2024-2036

2.3 Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

2.4 Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

2.5 Cardiovascular Surgery Devices Market, North America, Company Share by Revenue ($m), 2025

3 Cardiovascular Surgery Devices Market, Canada

3.1 Cardiovascular Surgery Devices Market, Canada, Revenue ($m), 2024-2036

3.1.1 Beating Heart Surgery Systems Market, Canada, Revenue ($m), by Segment, 2024-2036

3.1.2 Perfusion Disposables Market, Canada, Revenue ($m), by Segment, 2024-2036

3.2 Cardiovascular Surgery Devices Market, Canada, Volume (Units), 2024-2036

3.2.1 Beating Heart Surgery Systems Market, Canada, Volume (Units), by Segment, 2024-2036

3.2.2 Perfusion Disposables Market, Canada, Volume (Units), by Segment, 2024-2036

3.3 Cardiovascular Surgery Devices Market, Canada, Average Price ($), 2024-2036

3.4 Cardiovascular Surgery Devices Market, Canada, Company Share by Revenue ($m), 2025

4 Cardiovascular Surgery Devices Market, Mexico

4.1 Cardiovascular Surgery Devices Market, Mexico, Revenue ($m), 2024-2036

4.1.1 Beating Heart Surgery Systems Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.1.2 Perfusion Disposables Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.2 Cardiovascular Surgery Devices Market, Mexico, Volume (Units), 2024-2036

4.2.1 Beating Heart Surgery Systems Market, Mexico, Volume (Units), by Segment, 2024-2036

4.2.2 Perfusion Disposables Market, Mexico, Volume (Units), by Segment, 2024-2036

4.3 Cardiovascular Surgery Devices Market, Mexico, Average Price ($), 2024-2036

4.4 Cardiovascular Surgery Devices Market, Mexico, Company Share by Revenue ($m), 2025

5 Cardiovascular Surgery Devices Market, United States

5.1 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2024-2036

5.1.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2024-2036

5.1.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2024-2036

5.2 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2024-2036

5.2.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2024-2036

5.2.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2024-2036

5.3 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2024-2036

5.4 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2025

6 Cardiovascular Surgery Devices Market Pipeline Products

6.1 Cardiovascular Surgery Devices Market Pipeline Products

6.2 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development

6.3 Cardiovascular Surgery Devices – Pipeline Products by Segment

6.4 Cardiovascular Surgery Devices – Pipeline Products by Territory

6.5 Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path

6.6 Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date

7 Overview of Key Companies in North America Cardiovascular Surgery Devices Market

7.1 Abbott Laboratories

7.1.1 Company Overview

7.2 Getinge AB

7.2.1 Company Overview

7.3 LivaNova Plc

7.3.1 Company Overview

7.4 Nipro Corp

7.4.1 Company Overview

7.5 MicroPort Scientific Corp

7.5.1 Company Overview

7.6 Terumo Corp

7.6.1 Company Overview

7.7 Medtronic Plc

7.7.1 Company Overview

7.8 Fresenius SE & Co KGaA

7.8.1 Company Overview

8 Recent Developments

8.1 Corporate Communications

8.1.1 Apr 07, 2026: RWJUH Rahway Appoints Kenneth Janowski, DO, CPE as Chief Medical Officer

8.1.2 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range

8.1.3 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing

8.1.4 Nov 05, 2025: World Renowned Surgeon Completes 100th Robotic Heart Surgery at Baptist Health Miami

8.1.5 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms

8.1.6 Nov 04, 2025: Thoraflex Hybrid Graft Insertion In A Patient With Marfan Syndrome

8.1.7 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced

8.1.8 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing

8.1.9 Oct 20, 2025: Shasta Regional Medical Center Welcomes New Wound Care Specialist

8.1.10 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

8.1.11 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction

8.1.12 Oct 05, 2025: Genesee Biomedical Announces Matt Dambeck as CEO and Honors Woody Mathison’s Legacy

8.1.13 Oct 02, 2025: Baxter Health Foundation Achieves Two Million Dollar Goal for Heartbeat of Hope Campaign

8.1.14 Sep 25, 2025: BIDMC Appoints New Leaders in Cancer Pathology and Cancer Radiology

8.1.15 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.1.16 Sep 11, 2025: Riley Children’s Health Appoints Vanessa Roshell-Stacks as Vice President and Chief Operating Officer

8.1.17 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

8.1.18 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

8.2 Financial Announcements

8.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

8.2.2 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance

8.2.3 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

8.2.4 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range

8.2.5 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.2.6 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

8.2.7 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

8.2.8 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results

8.2.9 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

8.2.10 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

8.2.11 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

8.2.12 May 05, 2025: Integra LifeSciences Reports First Quarter 2025 Financial Results

8.3 Government and Public Interest

8.3.1 Mar 03, 2026: Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

8.3.2 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March

8.3.3 Feb 26, 2026: Picard Medical / SynCardia to Participate in Inaugural Hands-On Training Day at Technology and Heart Failure Therapeutics Conference

8.3.4 Feb 18, 2026: Medline Announces Participation in the Barclays 28th Annual Global Healthcare Conference

8.3.5 Dec 01, 2025: Integra LifeSciences Leadership to Present at Citi 2025 Global Healthcare Conference

8.3.6 Nov 10, 2025: MIMEDX to Participate in Upcoming Investor Conferences

8.3.7 Nov 05, 2025: Anumana to Present Advances in ECG-AI at AHA Scientific Sessions 2025

8.3.8 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

8.3.9 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.3.10 Aug 29, 2025: Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

8.3.11 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences

8.3.12 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule

8.4 Other Significant Developments

8.4.1 Feb 12, 2026: UP Health System – Marquette Offers New Procedure for Atrial Fibrillation

8.4.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.4.3 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms

8.4.4 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial

8.4.5 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.4.6 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction

8.4.7 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.4.8 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

8.4.9 Sep 08, 2025: Medline Partners With West Calcasieu Cameron Hospital for Prime Vendor Agreement

8.5 Product News

8.5.1 Apr 02, 2026: Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week

8.5.2 Apr 01, 2026: Picard Medical / Syncardia to Participate in Voice of the Patient Event During AZ Tech Week

8.5.3 Mar 20, 2026: Picard Medical / Syncardia to Present Its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session

8.5.4 Feb 26, 2026: Picard Medical / Syncardia to Participate in Inaugural “Hands-on Training Day” at the Technology and Heart Failure Therapeutics Conference

8.5.5 Feb 02, 2026: Artivion Announces Presentation of Positive New Clinical Data From NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting

8.5.6 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland

8.5.7 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing

8.5.8 Nov 20, 2025: Revisiting The Manougian Technique With Double-Patch

8.5.9 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared

8.5.10 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States

8.5.11 Nov 11, 2025: Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator System in Cardiac Surgeries

8.5.12 Nov 05, 2025: Anumana to Present Advances in ECG-AI at AHA Scientific Sessions 2025

8.5.13 Nov 05, 2025: Fluid Control Solutions For MedTech

8.5.14 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome

8.5.15 Oct 29, 2025: Penumbra Study Supports Lightning Flash

2.0 Mechanical Thrombectomy System

8.5.16 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing

8.5.17 Oct 24, 2025: Pulse Biosciences Announces First Patient Enrollment in NANOCLAMP AF Study

8.5.18 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets

8.5.19 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

8.5.20 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial

8.5.21 Sep 29, 2025: iHeartMedia and OSO Studios Launch Cardiac Cowboys Podcast Narrated by Chris Pine

8.5.22 Sep 29, 2025: Spur® Elute DEEPER Coronary Study Completes Enrollment

8.5.23 Sep 18, 2025: Modified Bex-Nikaidoh Operation In A Neonate With D-TGA, VSD, And PS

8.5.24 Sep 18, 2025: CMS Establishes New DRG 209 For Complex Aortic Arch Procedures

8.5.25 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death

8.5.26 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment

8.5.27 Sep 08, 2025: Microbot Medical Receives FDA Clearance for LIBERTY Endovascular Robotic System

8.6 Strategy And Business Planning

8.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland

8.6.2 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.

8.6.3 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets

8.6.4 Oct 07, 2025: Physiotika Announces Partnership With IonOptix in France

8.6.5 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo

8.6.6 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider

8.6.7 Sep 08, 2025: Medline Partners With West Calcasieu Cameron Hospital for Prime Vendor Agreement

9 Appendix

9.1 Research Methodology

9.1.1 Coverage

9.1.2 Secondary Research

9.1.3 Primary Research

9.1.4 Market Modeling and Forecasting

9.1.5 Company Share Analysis

9.1.6 Benchmarking

9.2 GlobalData Consulting

9.3 Contact Us

9.4 Disclaimer

Table

Table 1: Cardiovascular Surgery Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Table 2: Cardiovascular Surgery Devices Market, North America, Revenue ($m), USD Constant, 2024-2036

Table 3: Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

Table 4: Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

Table 5: Cardiovascular Surgery Devices Market, North America, Company Share by Revenue ($m), 2025

Table 6: Cardiovascular Surgery Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 7: Beating Heart Surgery Systems Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 8: Perfusion Disposables Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 9: Cardiovascular Surgery Devices Market, Canada, Volume (Units), 2024-2036

Table 10: Beating Heart Surgery Systems Market, Canada, Volume (Units), 2024-2036

Table 11: Perfusion Disposables Market, Canada, Volume (Units), 2024-2036

Table 12: Cardiovascular Surgery Devices Market, Canada, Average Price ($), 2024-2036

Table 13: Cardiovascular Surgery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 14: Cardiovascular Surgery Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 15: Beating Heart Surgery Systems Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 16: Perfusion Disposables Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 17: Cardiovascular Surgery Devices Market, Mexico, Volume (Units), 2024-2036

Table 18: Beating Heart Surgery Systems Market, Mexico, Volume (Units), 2024-2036

Table 19: Perfusion Disposables Market, Mexico, Volume (Units), 2024-2036

Table 20: Cardiovascular Surgery Devices Market, Mexico, Average Price ($), 2024-2036

Table 21: Cardiovascular Surgery Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025

Table 22: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 23: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 24: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 25: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2024-2036

Table 26: Beating Heart Surgery Systems Market, United States, Volume (Units), 2024-2036

Table 27: Perfusion Disposables Market, United States, Volume (Units), 2024-2036

Table 28: Cardiovascular Surgery Devices Market, United States, Average Price ($), 2024-2036

Table 29: Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 30: Cardiovascular Surgery Devices Market Pipeline Products

Table 31: Cardiovascular Surgery Devices – Pipeline Products by Stage of Development

Table 32: Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development

Table 33: Cardiovascular Surgery Devices – Pipeline Products by Segment

Table 34: Cardiovascular Surgery Devices – Pipeline Products by Territory

Table 35: Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path

Table 36: Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date

Table 37: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Cardiovascular Surgery Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Figure 2: Cardiovascular Surgery Devices Market, North America, Revenue ($m), USD Constant, 2024-2036

Figure 3: Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

Figure 4: Cardiovascular Surgery Devices Market, North America, Volume (Units), 2024-2036

Figure 5: Cardiovascular Surgery Devices Market, North America, Company Share (%), 2025

Figure 6: Cardiovascular Surgery Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 7: Beating Heart Surgery Systems Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 8: Perfusion Disposables Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 9: Cardiovascular Surgery Devices Market, Canada, Volume (Units), 2024-2036

Figure 10: Beating Heart Surgery Systems Market, Canada, Volume (Units), 2024-2036

Figure 11: Perfusion Disposables Market, Canada, Volume (Units), 2024-2036

Figure 12: Cardiovascular Surgery Devices Market, Canada, Company Share (%), 2025

Figure 13: Cardiovascular Surgery Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 14: Beating Heart Surgery Systems Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 15: Perfusion Disposables Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 16: Cardiovascular Surgery Devices Market, Mexico, Volume (Units), 2024-2036

Figure 17: Beating Heart Surgery Systems Market, Mexico, Volume (Units), 2024-2036

Figure 18: Perfusion Disposables Market, Mexico, Volume (Units), 2024-2036

Figure 19: Cardiovascular Surgery Devices Market, Mexico, Company Share (%), 2025

Figure 20: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 21: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 22: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 23: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2024-2036

Figure 24: Beating Heart Surgery Systems Market, United States, Volume (Units), 2024-2036

Figure 25: Perfusion Disposables Market, United States, Volume (Units), 2024-2036

Figure 26: Cardiovascular Surgery Devices Market, United States, Company Share (%), 2025

Figure 27: Cardiovascular Surgery Devices – Pipeline Products by Stage of Development

Figure 28: Cardiovascular Surgery Devices – Pipeline Products by Segment

Figure 29: Cardiovascular Surgery Devices – Pipeline Products by Territory

Figure 30: Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path

Figure 31: Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date

North America Cardiovascular Surgery Devices Market Outlook to 2036 – Beating Heart Surgery Systems and Perfusion Disposables standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

North America Cardiovascular Surgery Devices Market Outlook to 2036 – Beating Heart Surgery Systems and Perfusion Disposables was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Cardiovascular Surgery Devices Market Outlook to 2036 – Beating Heart Surgery Systems and Perfusion Disposables in real time.

  • Access a live North America Cardiovascular Surgery Devices Market Outlook to 2036 – Beating Heart Surgery Systems and Perfusion Disposables dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more